一个in silico方法来阐明导致初级骨质疏松症的途径:与年龄相关的与绝经后的相比
Rocío Ruiz-Lozano1, José Luis Calvo-Gallego1, Peter Pivonka2
1Departmento de Ingeniería Mecánica y Fabricación, Universidad de Sevilla, 41092, Seville, Spain.
Biomechanics and modeling in mechanobiology
|May 3, 2024
概括
这项研究通过结合衰老和雌激素下降来模拟骨损失. 它发现,硬质素的增加是衰老骨质损失的关键,如果太早开始治疗骨质疏松症,那么denosumab对骨质疏松症的治疗效果会降低.
科学领域:
- 生物医学工程 生物医学工程
- 计算生物学 计算生物学
- 骨质疏松症研究 骨质疏松症研究
背景情况:
- 传统的骨改造模型模拟雌激素的下降,但忽视了衰老对骨质损失的影响.
- 了解衰老和雌激素缺乏的综合影响对于开发有针对性的骨质疏松症疗法至关重要.
研究的目的:
- 调整骨细胞种群模型,以纳入衰老和雌激素缺乏对骨重塑的影响.
- 调查衰老和雌激素下降对骨矿物质密度 (BMD) 的不同和联合影响.
主要方法:
- 调整了骨细胞模型,以包括衰老的影响:TGF-β降低和增加硬质素的产生.
- 通过增加RANKL,减少OPG和增强骨质细胞响应能力来模拟雌激素缺乏.
- 使用男性和女性的BMD横截面数据验证了该模型.
主要成果:
- 增加的硬质素生产显著导致与年龄相关的骨质损失,比降低的TGF-β.
- 模拟的雌激素缺乏机制产生了类似的骨损失结果.
- 早期更年期导致第五个十年的BMD较低,但在第六个十年后这种差异减少了.
结论:
- 综合模型准确地反映了与年龄和雌激素相关的骨损失机制.
- 在绝经后10年内或60岁之前开始使用登苏马布治疗骨质疏松症时,疗效降低.
更多相关视频
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
498
07:12Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
Published on: September 28, 2017
8.2K
相关概念视频
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Menopause
156
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
156
